Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Return on Equity (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Return on Equity for 8 consecutive years, with 0.91% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 56.0% to 0.91% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.91% through Dec 2025, down 56.0% year-over-year, with the annual reading at 0.01% for FY2025, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 0.91% at Precision Biosciences, up from 3.39% in the prior quarter.
  • The five-year high for Return on Equity was 0.42% in Q2 2024, with the low at 3.39% in Q3 2025.
  • Average Return on Equity over 5 years is 0.91%, with a median of 0.79% recorded in 2023.
  • The sharpest move saw Return on Equity skyrocketed 161bps in 2021, then plummeted -339bps in 2025.
  • Over 5 years, Return on Equity stood at 0.41% in 2021, then tumbled by -151bps to 1.02% in 2022, then increased by 23bps to 0.78% in 2023, then soared by 55bps to 0.35% in 2024, then tumbled by -159bps to 0.91% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.91%, 3.39%, and 2.06% for Q4 2025, Q3 2025, and Q2 2025 respectively.